OMICS Gene Silencing news from GENWhat's new in transcriptional and post-transcriptional regulation. Thursday, March 13, 2008http://www.genengnews.com/news/newslist.aspx?taxid=15 Silence Therapeutics and AstraZeneca Announce Collaboration to Develop Novel Approaches for siRNA Drug Delivery Thursday, March 13, 2008 http://www.genengnews.com/news/bnitem.aspx?name=32011190 Calando Files IND for siRNA Nanoparticle Therapeutic in Oncology Thursday, March 13, 2008 http://www.genengnews.com/news/bnitem.aspx?name=31997828 Arrowhead Subsidiary, Calando Pharmaceuticals, Submits IND for Clinical Trial with Targeted, Nano-Delivered RNAi Therapeutic for Cancer Thursday, March 13, 2008 http://www.genengnews.com/news/bnitem.aspx?name=31991316 Initial Trading of RXi Pharmaceuticals Begins Today on the NASDAQ Capital Market Under Symbol RXII Wednesday, March 12, 2008 http://www.genengnews.com/news/bnitem.aspx?name=31948945 Oncolys BioPharma and Tacere Therapeutics Sign Strategic Alliance and License Agreement to Develop and Commercialize RNAi Hepatitis C Drug Wednesday, March 12, 2008 http://www.genengnews.com/news/bnitem.aspx?name=31951602 Sirnaomics and GRL Establish Partnership for the Development of Two Multi-Targeted RNAi Therapeutics Products Wednesday, March 12, 2008 http://www.genengnews.com/news/bnitem.aspx?name=31945912